EMEA-001477-PIP01-13

Key facts

Active substance
  • Ezetimibe
  • Atorvastatin
Therapeutic area
Cardiovascular diseases
Decision number
P/0273/2013
PIP number
EMEA-001477-PIP01-13
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of elevated cholesterol
Route(s) of administration
Oral use
Contact for public enquiries
Althera Laboratoires Limited
Republic of Ireland
E-mail: charmaine.dias@altherainc.com
Tel. +353 1 906 0479
Fax +353 1 906 0480
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating